Psych Hospital Settles FCA Case for $2.85M Over Detox Level of Care

By Nina Youngstrom

A psychiatric hospital in Pennsylvania agreed to pay $2.85 million to settle false claims allegations that it billed Medicare, Medicaid and the Federal Employees Health Benefits Program for hospital-level detoxification when patients only qualified for residential detoxification or there wasn’t documentation to support the higher level of service. As part of the settlement, Eagleville Hospital entered into a five-year corporate integrity agreement, the U.S. Attorney’s Office for the Eastern District of Pennsylvania said July 24.

The case was set in motion by Christopher Smith, a former nurse at 308-bed Eagleville Hospital, who filed a whistleblower complaint. He began working at the hospital in 2005 and became an evening shift nursing supervisor in 2015.

Eagleville Hospital provides both hospital-level and nonhospital-level residential treatment for substance use disorders. The definition of inpatient hospital is “the provision of detoxification or treatment and rehabilitation services, or both, 24 hours a day, in a hospital,” according to the Pennsylvania Department of Drug and Alcohol Programs. Inpatient nonhospital is “a nonhospital, residential facility, providing one or both of the following services: treatment and rehabilitation or detoxification. The client resides at the facility.”

This document is only available to subscribers. Please log in or purchase access.


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field